Quent Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$444K Sell
6,281
-912
-13% -$68.3K 0.03% 223
2025
Q4
$568K Sell
7,193
-121
-2% -$9.58K 0.04% 200
2025
Q3
$602K Buy
7,314
+312
+4% +$24.6K 0.05% 142
2025
Q2
$563K Buy
7,002
+20
+0.3% +$1.54K 0.05% 145
2025
Q1
$561K Sell
6,982
-122
-2% -$10.1K 0.06% 122
2024
Q4
$582K Sell
7,104
-408
-5% -$34K 0.06% 126
2024
Q3
$620K Sell
7,512
-235
-3% -$17.6K 0.06% 160
2024
Q2
$544K Sell
7,747
-283
-4% -$20.2K 0.06% 161
2024
Q1
$595K Buy
8,030
+347
+5% +$24.2K 0.07% 152
2023
Q4
$508K Buy
7,683
+359
+5% +$22.5K 0.07% 165
2023
Q3
$461K Buy
7,324
+392
+6% +$24.4K 0.07% 160
2023
Q2
$392K Buy
6,932
+125
+2% +$6.94K 0.06% 186
2023
Q1
$394K Sell
6,807
-159
-2% -$10.7K 0.07% 183
2022
Q4
$504K Buy
6,966
+9
+0.1% +$645 0.09% 132
2022
Q3
$423K Buy
6,957
+26
+0.4% +$1.66K 0.09% 144
2022
Q2
$435K Buy
6,931
+375
+6% +$24.8K 0.09% 132
2022
Q1
$461K Buy
6,556
+1,307
+25% +$88.4K 0.09% 156
2021
Q4
$328K Buy
+5,249
New +$329K 0.07% 206

Other funds holding MET

Quent Capital's MET Position: Q1 2026 in Review

Quent Capital reduced its MetLife (MET) stake by 13% in Q1 2026, selling an estimated $68.3K and leaving 6,281 shares worth $444K. The position accounts for 0.03% of the portfolio, ranked #223.

Quent Capital first reported a position in MET in Q4 2021 and has held it in 18 quarters since. The position peaked at $620K in Q3 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Quent Capital held 6,281 shares of MetLife worth $444K as of Q1 2026.
  • Quent Capital sold 912 MetLife shares in Q1 2026, an estimated $68.3K.
  • MetLife made up 0.03% of Quent Capital's portfolio in Q1 2026, its #223 holding.
  • Quent Capital first reported a position in MetLife in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's MetLife position peaked at $620K in Q3 2024.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.